Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for Chagas Disease
Author Information
Author(s): Mukherjee Shankar, Machado Fabiana S., Huang Huang, Oz Helieh S., Jelicks Linda A., Prado Cibele M., Koba Wade, Fine Eugene J., Zhao Dazhi, Factor Stephen M., Collado J. Elias, Weiss Louis M., Tanowitz Herbert B., Ashton Anthony W.
Primary Institution: Albert Einstein College of Medicine
Hypothesis
What effect does NSAID use have on the development of acute and chronic Chagas disease?
Conclusion
Aspirin treatment increased mortality and parasitemia during acute infection but improved cardiac function when administered during the chronic phase.
Supporting Evidence
- Aspirin treatment increased mortality during acute infection in a dose-dependent manner.
- Delayed aspirin treatment improved ejection fraction in infected mice.
- ASA treatment diminished the profile of circulating prostaglandins in infected mice.
- COX-1 null mice displayed increased parasitemia compared to ASA-treated infected mice.
- Expression of SOCS-2 was enhanced in the spleens of infected ASA-treated mice.
Takeaway
Giving aspirin to mice infected with a parasite made them sicker at first, but helped their hearts later on.
Methodology
Mice were infected with Trypanosoma cruzi and treated with aspirin at different stages of infection to assess mortality and parasitemia.
Potential Biases
Potential bias in interpreting the effects of aspirin due to its known off-target effects.
Limitations
The study primarily used a single mouse strain and focused on specific dosages of aspirin.
Participant Demographics
Male CD-1 mice were used in the experiments.
Statistical Information
P-Value
p≤0.05
Statistical Significance
p≤0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website